Why the study?
Does a vascularized cardiac patch (BMV-CSC patch) improve cardiomyocyte proliferation and neovascularization compared to conventional CSC patches in a rat model of acute myocardial infarction?
Population
Rat model of acute myocardial infarction and human umbilical vein endothelial cells with human cardiac stem…
Comparison
Vascularized cardiac patch created using… vs Conventional CSC patches and coculture of…
Design
Preclinical
Follow-up
4 weeks (in vivo), 7 days (in vitro)
Key result
In a rat model of acute MI, the BMV-CSC patch significantly increased myocardial capillary density compared to conventional CSC patches at 4 weeks post-treatment.
Authors
Loading...
Microengineered CSC patches may boost post-MI repair in animals; leaves open clinical translation and human efficacy trials.
Does a vascularized cardiac patch (BMV-CSC patch) improve cardiomyocyte proliferation and neovascularization compared to conventional CSC patches in a rat model of acute myocardial infarction?
A novel vascularized cardiac patch integrating biomimetic microvessels and cardiac stem cells significantly enhances cardiomyocyte proliferation and neovascularization after acute myocardial infarction in a rat model.
Su et al. (2018) studied Acute myocardial infarction. Vascularized cardiac patch (BMV-CSC patch) vs. Conventional CSC patches was evaluated on Myocardial capillary density and cardiomyocyte mitotic activities. In a rat model of acute MI, the BMV-CSC patch significantly increased myocardial capillary density compared to conventional CSC patches at 4 weeks post-treatment.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: